by inflammation, malignancy and chronic illnesses.
Genetic disorders for example epidermolysis bullosa
(EB) will not be covered. We also want to highlight
that this is an educational and state of the art
document. The level of evidence is not given but it
is a literature review of available evidence.
The aim of the document is to:
• Present the diagnostic criteria, comorbidities and
diagnostic tools for wounds defined as atypical,
including practical hints for health professionals.
• Present the best available documented current
treatment options. High-quality evidence
is sparse, but there are retrospective and
observational studies as well as some randomised
• Present some newer treatment options for
• Reduce the diagnostic delay with these wounds by
providing up to date evidence based literature on
atypical wounds and an algorithm to aid clinicians
in assessing these wounds in a systematic way
(see algorithm in Chapter 12 Practical aspects of
diagnosing and treating atypical wounds).